VIENNA, April 21, 2017 /PRNewswire/ — At the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Bruker tomorrow will introduce important new clinical microbiology assays and consumables kits to further enhance the MALDI Biotyper® (MBT) platform. Bruker will also introduce novel, real-time PCR assays and kits for fast molecular testing of invasive aspergillosis... Read more
CAMBRIDGE, UK and SAN DIEGO, USA – April 20, 2017 – Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases which otherwise takes months or years.... Read more
Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more
Thermo Fisher Scientific Inc. today announced that results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have been published in the May 2017 print issue of Critical Care Medicine. Researchers from the study, titled “Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study,” investigated the use of... Read more
Thermo Fisher Scientific has signed an agreement with the Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland, to establish the leading institution as the first partner in the Next Generation Sequencing Companion Dx Center of Excellence Program, a new initiative designed to develop and refine Thermo Fisher’s NGS-based research assays from its... Read more
BREA, California – April 20, 2017 Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis Beckman Coulter Diagnostics announced a partnership with Diazyme Laboratories that allows customers access to a procalcitonin (PCT) assay, an important marker for the detection and management of bacterial infections and sepsis. The high-quality, fully... Read more
Menu to include Procalcitonin (PCT)Beckman Coulter Sample Press Release Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis BREA, CALIF. — (April 20, 2017) — Beckman Coulter Diagnostics announced a partnership with Diazyme Laboratories that allows customers access to a procalcitonin (PCT) assay, an important marker for the detection... Read more
April 19, 2017 12:07 PM Pacific Daylight Time MADISON, Wis.–(BUSINESS WIRE)–Cellular Dynamics International (CDI), a FUJIFILM company and a leading developer and manufacturer of induced pluripotent stem cells (iPS), today announced it has signed a collaboration agreement with the Harvard Stem Cell Institute (HSCI), a novel network of stem cell scientists that extends from the... Read more
Agreement centered on next-generation sequencing oncology research and companion diagnostic development programs CARLSBAD, Calif., April 18, 2017 /PRNewswire/ — Thermo Fisher Scientific has signed an agreement with the Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland, to establish the leading institution as the first partner in the Next Generation Sequencing Companion Dx Center... Read more
Proceeds Intended to Facilitate Completion of Merger with Precipio Diagnostics During Second Quarter of 2017 OMAHA, Neb. (April 17, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that it has received $1.15 million in proceeds from a note bridge financing.The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC,... Read more